Wistar Wire: Melanoma

Ben Leach
(l to r) Kate O'Neill and Meenhard Herlyn listen to Gordon B. Mills
(l to r) Kate O'Neill and Meenhard Herlyn listen to Gordon B. Mills
The speakers covered the major challenges facing melanoma patients today, including therapy resistance and metastastic disease, and the latest advances in science that will help improve treatment.
Cancer, Events, Melanoma
Ben Leach
Amanpreet Kaur, Ph.D.
Amanpreet Kaur, Ph.D.
Amanpreet Kaur, Ph.D., recently completed a joint Ph.D. program between University of the Sciences and The Wistar Institute that sets the stage for her continued cancer research efforts.
Cancer, Melanoma
Ben Leach
Several new scientific studies by Wistar researchers covered a variety of cancers and identified possible new treatment options.
Ben Leach
Ashani Weeraratna, Ph.D.
Ashani Weeraratna, Ph.D.
Melanoma, even more than other cancer types, is a “disease of aging,” whose incidence increases and whose outcome worsens with age. This was the take home message from the latest installment of Wistar’s Women and Science Program featuring Ashani Weeraratna, Ph.D.
Cancer, Events, Melanoma